Devices for stent advancement

Information

  • Patent Grant
  • 8876881
  • Patent Number
    8,876,881
  • Date Filed
    Monday, October 22, 2007
    16 years ago
  • Date Issued
    Tuesday, November 4, 2014
    9 years ago
Abstract
Devices and methods for stent advancement, including methods for instructing another or others how to advance a stent into an anatomical structure or into a testing/demonstration synthetic structure, such as a polymer tube. The advancement may be achieved by at least two periods of stent engagement that drive a stent distally from a sheath separated by a period of non-engagement.
Description
BACKGROUND

1. Field


The present invention relates generally to devices and methods for stent placement, such as in a body vessel or duct or in a structure used for testing or demonstration (such as a polymer tube), and to methods of instructing one or more individuals on stent placement.


2. Description of Related Art


Examples of stent delivery devices are included in U.S. Pat. Nos. 5,372,600; 5,433,723; 5,707,376; 5,772,668; 5,776,142; 5,968,052; 6,514,261; 6,599,296; 7,052,511; 7,122,050; U.S. Pat. App. Pub. No. 20030040772; and U.S. Pat. App. Pub. No. 20050021123.


SUMMARY OF THE INVENTION

Some embodiments of the present devices (which also may be characterized as stent deployment devices) include an outer sheath; a stent disposed within the outer sheath, the stent having a distal end and a proximal end; a stent-engaging element positioned at least partially within the lumen of the stent; and a stent-retention element coupled to the proximal end of the stent; where the device is configured such that: the stent-engaging element can be operated in a reciprocating manner to engage and advance the stent distally at least partially out of the outer sheath; and the stent-retention element will stay in contact with the stent during proximal movement of the stent-engaging element provided that the proximal end of the stent is disposed within the outer sheath.


Some embodiments of the present devices include an outer sheath; a stent disposed within the outer sheath, the stent having a lumen, a distal end and a proximal end; an inner element positioned at least partially within the lumen of the stent, the inner element being configured to accept a guidewire; and a stent-engaging element positioned at least partially within the lumen of the stent and being capable of moving distally and proximally while the inner element is stationary; where the device is configured to distally drive the stent at least partially out of the outer sheath through at least two periods of engagement of the stent by the stent-engaging element that are separated by a period of non-engagement that does not drive the stent distally.


Some embodiments of the present devices include an outer sheath; a handle coupled to the outer sheath such that the outer sheath cannot move relative to the handle, the handle having a proximal end; a stent disposed within the outer sheath, the stent having a lumen, a distal end and a proximal end; and a stent-engaging element positioned at least partially within the lumen of the stent; where the device is configured such that: a user can advance the stent distally out of the outer sheath through at least two periods of engagement of the stent by the stent-engaging element that drive the stent distally and that are separated by a period of non-engagement that does not drive the stent distally; and the user's proximal-most point of contact with the device that causes each period of engagement is located at or distal of the proximal end of the handle.


Some embodiments of the present devices include an outer sheath; a stent disposed within the outer sheath, the stent having a distal end and a proximal end; a reciprocating element disposed at least partially within the outer sheath, the reciprocating element having a stent-engaging portion (which also may be characterized as a stent-engaging element); a user-actuatable element coupled to the reciprocating element; and a stent-retention element coupled to the proximal end of the stent; wherein: the stent-engaging portion is operable in a reciprocating manner to engage and advance the stent distally at least partially out of the outer sheath; and the stent-retention element stays in contact with the stent during proximal movement of the stent-engaging portion provided that the proximal end of the stent is disposed within the outer sheath.


Some embodiments of the present devices include an outer sheath; a stent disposed within the outer sheath, the stent having a distal end and a proximal end; a device body coupled to the outer sheath; a reciprocating element disposed at least partially within the outer sheath, the reciprocating element having a stent-engaging portion; and a user-actuatable element mounted on the device body and coupled to the reciprocating element; wherein the device is configured such that the stent-engaging portion is operable in a reciprocating manner to engage and advance the stent at least partially out of the outer sheath, and the outer sheath need not move relative to the device body in order for the stent-engaging portion to advance the stent.


Some embodiments of the present devices include an outer sheath; a stent disposed within the outer sheath, the stent having a distal end and a proximal end; a device body coupled to the outer sheath; a hollow reciprocating element disposed at least partially within the outer sheath, the hollow reciprocating element having a stent-engaging portion; a user-actuatable element mounted on the device body and coupled to the hollow reciprocating element; a stent-retention element coupled to the proximal end of the stent; and an inner tube disposed at least partially within the outer sheath, a portion of the inner tube being at least partially within the hollow reciprocating element; wherein: the hollow reciprocating element is operable to move (a) distally in response to a user moving the user-actuatable element distally and (b) proximally in response to a user moving the user-actuable element proximally; the stent-engaging portion is operable in a reciprocating manner to engage and advance the stent at least partially out of the outer sheath; the outer sheath need not move relative to the device body in order for the stent-engaging portion to advance the stent; the stent-retention element stays in contact with the stent during proximal movement of the stent-engaging portion provided that the proximal end of the stent is disposed within the outer sheath; and the stent-retention element is operable to withdraw the stent proximally back into the outer sheath provided that a proximal portion of the stent is disposed within the outer sheath.


Some embodiments of the present stent advancement methods include advancing a stent disposed within a sheath disposed within a body vessel using a multiple reciprocating movements of a reciprocating element, where: each reciprocating movement includes a distal movement of the reciprocating element and a proximal movement of the reciprocating element; the stent is advanced distally in response to each distal movement of the reciprocating element; the stent is not advanced in response to each proximal movement of the reciprocating element; and each distal movement of the reciprocating element does not coincide with a separate proximal movement of the sheath.


Some embodiments of the present stent advancement methods include distally driving a stent out of a sheath and into a tubular structure by repeatedly engaging the stent between its distal and proximal ends with a stent-engaging element, where at least two of the engagements are separated by a period of non-engagement; and as the stent is distally driven out of the sheath, varying the axial density of the stent within the tubular structure by varying the axial position of the sheath relative to the tubular structure.


Some embodiments of the present stent advancement instruction methods include instructing a person on how to use a stent delivery device that includes a sheath and a stent disposed in the sheath, the instructing including demonstrating the following steps to the person: distally driving the stent out of the sheath and into a tubular structure by repeatedly engaging the stent between its distal and proximal ends with a stent-engaging element, where at least two of the engagements are separated by a period of non-engagement; and as the stent is distally driven out of the sheath, varying the axial density of the stent within the tubular structure by varying the axial position of the sheath relative to the tubular structure.


Any embodiment of any of the present devices and methods may consist of or consist essentially of—rather than comprise/include/contain/have—the described features and/or steps.


Details associated with these embodiments and others are provided below.





BRIEF DESCRIPTION OF THE DRAWINGS

The following drawings illustrate by way of example and not limitation. They illustrate two different embodiments of the present delivery devices, the second of which appears in FIGS. 13 and 14. They also illustrate the manner in which stent density can be altered during delivery (FIGS. 15A-15C), and a schematic of one of the present demonstration techniques (FIG. 16).



FIGS. 1, 2A, 2B, 2C, 3A, 3B, 3D, 3E, 4-7, 11, 12A, 13, and 14 are drawn to scale (in terms of proportions), save the length of line 72, which can be varied as desired. Identical reference numerals do not necessarily indicate an identical structure. Rather, the same reference numeral may be used to indicate a similar feature or a feature with similar functionality. Not every feature of each embodiment is labeled in every figure in which that embodiment appears, in order to keep the figures clear.



FIG. 2D is a cross-sectional view of a sub-assembly of an embodiment of device.



FIG. 3C is a cross-sectional view of a sub-assembly of an embodiment of device.



FIG. 8 provides a schematic depiction of the stent advancement process.



FIG. 9 depicts stent in a constrained, or elongated, configuration.



FIG. 10 shows stent in an expanded state in body vessel.



FIG. 12B shows an embodiment of stent-retention element.





DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

The terms “comprise” (and any form of comprise, such as “comprises” and “comprising”), “have” (and any form of have, such as “has” and “having”), “contain” (and any form of contain, such as “contains” and “containing”), and “include” (and any form of include, such as “includes” and “including”) are open-ended linking verbs. As a result, a device or method that “comprises,” “has,” “contains,” or “includes” one or more elements possesses those one or more elements, but is not limited to possessing only those one or more elements or steps. Likewise, an element of a device or a step of a method that “comprises,” “has,” “contains,” or “includes” one or more features possesses those one or more features, but is not limited to possessing only those one or more features. Furthermore, a structure that is configured in a certain way must be configured in at least that way, but also may be configured in a way or ways that are not specified.


Any embodiment of any of the present devices and methods may consist of or consist essentially of—rather than comprise/include/contain/have—the described features and/or steps.


The terms “a” and “an” are defined as one or more than one unless this disclosure explicitly requires otherwise. The terms “substantially” and “about” are defined as at least close to (and include) a given value or state (preferably within 10% of, more preferably within 1% of, and most preferably within 0.1% of).


An illustrative embodiment of the present devices appears in perspective in FIG. 1. Device 10 includes outer sheath 20 and device body 90 (which, in this embodiment, is a handle configured to be held in one hand) coupled to outer sheath 20. In this embodiment, the outer sheath is coupled to the handle such that the outer sheath cannot move relative to the handle (that is, the two are coupled to each other in a fixed relationship). Outer sheath 20 is a hollow member configured such that a stent can be disposed within it when the stent is in a constrained (e.g, elongated) state prior to delivery.


A portion of the embodiment of FIG. 1 near device body 90 is illustrated in perspective in FIG. 2A and in cross-section in FIG. 3. These figures show that device 10 includes user-actuatable element 50 that is coupled to (and, in this embodiment, mounted on so as to be slidable with respect to) device body 90 and also coupled to element 40, which in this embodiment has a passageway and is configured to fit within outer sheath 20. In the embodiment shown in FIGS. 2A and 3A, user-actuatable element 50 is slidably mounted on device body 90 and coupled to element 40 via block 51. In some embodiments, block 51 may include a biasing element (such as a spring) that biases user-actuatable element 50 toward the position shown in FIG. 3A. In other embodiments, block 51 does not include a biasing element.


User-actuatable element 50, block 51, and element 40 of device 10 are moveable in the proximal and distal directions (which is along the longitudinal axis (not shown) of the device), and are generally constrained in other directions. Thus, proximal movement of user-actuatable element 50 (towards proximal side 92) results in proximal movement of element 40, and distal movement of user-actuatable element 50 (towards distal side 91) results in distal movement of element 40. In the depicted embodiment, the distance that user-actuatable element 50 moves (either proximally or distally) will translate into movement of element 40 by the same distance. This translation could be geared up or down as desired. As explained in greater detail below, element 40 is coupled to stent-engaging element 45, which engages and drives the loaded stent distally from the outer sheath during at least a portion of the time the stent-engaging element is moved distally within the lumen of the stent.



FIG. 2A also shows that device 10 may include an element 25 that is coupled (slidably) to the outside of outer sheath 20. Element 25 can be configured to slide relatively freely along the outer surface of the outer sheath, and it can be configured to interface with a hemostasis valve of an introducer (see FIG. 3B). Specifically, in can be configured to fit partially inside the introducer and interface with the hemostasis valve such that fluid does not flow back toward the handle of the device yet the outer sheath of the device can slide relatively freely within element 20 and the introducer. Effectively, element 25 can act to reduce the friction between the outer sheath of the device and an introducer through which the outer sheath of the device is inserted, while maintaining a substantial fluid seal between the outer sheath and the exterior of the patient.


Referring to FIGS. 1, 4 and 5, outer sheath 20 extends distally from device body 90. Device 10 also includes inner element 60, a portion of which is located within outer sheath 20. Inner element 60 (and, more specifically in the preferred embodiment, inner sleeve 61 as shown in FIG. 2D, described below) is coupled at its distal end to nose cone 150. Inner element 60, which is not constrained axially by sheath 20 (in that the two have sufficiently different diameters that they do not touch), facilitates motion of nose cone 150 relative to outer sheath 20 and it is sized such that a guidewire may be passed through it (as is nose cone 150). Radiopaque marker 27 may be placed at any suitable location along outer sheath 20 in order to provide a means for aiding deployment of a stent. For example, the distance from the distal end of outer sheath 20 and marker 27 may be the nominal length of the stent being delivered in its deployed state. FIG. 5 illustrates distal end 31 of stent 30 within outer sheath 20. In some embodiments, neither element 40 nor stent-engaging element 45 is attached to inner element 60. As a result, element 40 may be moved proximally and over inner element 60 while inner element 60 is stationary. Similarly, stent-engaging element 45 may be moved proximally and distally over inner element 60 while inner element 60 is stationary.


Returning to FIGS. 2A and 3A and referring also to FIG. 2C, the allowable proximal-distal travel of user-actuatable element 50 is constrained by the length of slot 52 in device body 90, as well the position of stopper 120. First position 121 of stopper 120 shown in FIG. 2A limits the distal travel of user-actuatable element 50 to less than the full length of slot 52. Preferably, first position 121 corresponds to a distal-most position of user-actuatable element 50 where the stent-engaging element 45 remains within outer sheath 20. This corresponds to the proper configuration for advancement of stent 30. Stopper 120 is preferably biased to first position 121 with, e.g, a spring. In FIGS. 2C and 3A, stopper 120 has been rotated to a second position 122 (labeled as such in FIG. 2C) that allows user-actuatable element 50 to slide past it, as shown.



FIG. 2D is a cross-sectional view of a sub-assembly of a preferred embodiment of device 10, which sub-assembly includes a preferred embodiment of inner element 60 in the form of an inner sleeve 61 that extends the length of inner element 60 and that is configured to accept a guidewire. Inner element 60 may also include intermediate sleeve 62 that may be secured at its distal end (or any other suitable location) to inner sleeve 61 in any suitable fashion, such as Loctite® 4014 adhesive. Intermediate sleeve 62 (which may be a hypotube) also may extend to the proximal end of inner element 60. Inner element 60 may also include outer sleeve 63 (which may be a hypotube) connected at its distal end (or any other suitable location) to intermediate sleeve 62 in any suitable manner, such as through soldering; outer sleeve 63 also may extend to the proximal end of inner element 60. Inner element 60 may also include a travel-limiting sleeve 64 connected at its distal end (or any other suitable location) to outer sleeve 63 in any suitable manner, such as through soldering. Sleeve 64 may be configured to restrict the travel of inner element 60 with respect to device body 90. More specifically, sleeve 64 can be configured to interfere (due to its size) with the proximal opening (not labeled) of cavity 55 of device body 90 (see FIG. 3A), and it can be configured to interfere distally with block 51 (if Luer fitting 100 does not first interfere with Y-adapter 95).



FIG. 3B is an enlarged, cross-sectional view, showing the interaction between element 25 and introducer 35, where element 25 is interfacing with seal 31 of the hemostasis valve of introducer 35.



FIG. 3C is a cross-sectional view of a sub-assembly of a preferred embodiment of device 10, which sub-assembly includes a preferred embodiment of element 40 in the form of proximal hypotube 41 secured in any suitable fashion to block 51, such as by a press fit that terminates at shoulder 57 or with a suitable adhesive, such as one of the Loctite® adhesives (e.g., 4014, 4305, 3321, etc.). Block 51 is secured to user-actuatable element 50 through pin 54, which can be bonded to element 50 and press fit or bonded to block 51. Element 40 may also include an intermediate tube 42 that is connected at its proximal end to proximal hypotube 41 in any suitable manner, such as through Loctite® 4305, and at its distal end to support tube 46 (that is in turn connected to stent-engaging element 45 in any suitable fashion, such as an adhesive) in any suitable manner, such as through an adhesive. Element 40 may also include a support tube 43 that is positioned over intermediate tube 42 and that abuts the distal end of proximal hypotube 41. Support tube 43 may be connected at any suitable location to intermediate tube 42 using any suitable adhesive. The support tube may be configured to increase the rigidity of intermediate tube 42. Element 40 may also include resheathing stop 44 that is threaded over intermediate tube 42 and that abuts the distal end of support tube 43. Resheathing stop 44 may be connected at any suitable location to intermediate tube 42 using any suitable adhesive. Resheathing stop 44 may be configured to prevent proximal movement of the stent that is enclosed by outer sheath 20 (not shown in this figure) should the stent be re-sheathed during the delivery process. The depicted sub-assembly also includes a silicone seal 56 that is designed to prevent the backflow of fluid around the outside of inner element 60 (and, more specifically, an outer hypotube that is part of a preferred embodiment of inner element 60) and that is held in place by a stainless steel retainer 58.


Referring to FIG. 6, element 40 extends such that a portion of it is located within outer sheath 20. Preferably, element 40 is hollow and its passageway accommodates a portion of inner tube 60 being located within it. Alternate embodiments of this element may be non-hollow.


Referring to FIGS. 6-7, element 40 is coupled to a stent-engaging element 45, which, in this embodiment, is shaped like a shovel or scoop. More specifically, in the depicted preferred embodiment, intermediate tube 42 of element 40 is connected to support tube 46, which is connected to stent-engaging element 45. Stent-engaging element 45 is positioned at least partially within the lumen of stent 30. As element 40 moves distally in response to distal movement of user-actuatable element 50, stent-engaging element 45 engages stent 30, advancing it along outer sheath 20. In a preferred embodiment, proximal motion of stent-engaging portion 45 results in no motion of stent 30. Repeated reciprocating distal and proximal motion of element 40 in this manner results in advancement of stent 30 until it exits outer sheath 20. Thus, those of ordinary skill in the art will understand that the illustrated embodiment of device 10 is configured such that a user can advance stent 30 distally out of outer sheath 20 through multiple engagements of the stent by stent-engaging element 45, where each engagement: occurs between the proximal and distal ends of stent 30, drives stent 30 distally without a mechanized concomittant withdrawal of outer sheath 20, and is separated from any subsequent engagement by a period of not driving stent 30 distally; and the user's proximal-most point of contact with device 10 that causes each engagement (which occurs at user-actuatable element 50) is located at or distal of the proximal end of device body 90. Stent-engaging element 45 may include a flex slot 48 provided with rounded, dumbbell-shaped ends that help alleviate fatigue stress fractures and the like and that allow element 45 to fold inwardly as it slides proximally within the lumen of stent 30. Preferably, the performance of stent-engaging portion 45 is achieved by appropriate shape selection, as depicted in FIG. 7. Alternate embodiments may employ stent-engaging portions that flex, are hinged, or otherwise change shape to achieve stent advancement. The configuration of the stent-engaging portion may be chosen to best suit the type of stent to be deployed. When stent 30 is a woven, self-expanding stent, such as the kind disclosed in U.S. Pat. No. 7,018,401, which is incorporated by reference, stent-engaging element 45 is preferably configured (as shown in the figures) so as to (a) engage wire intersections on opposing sides of stent 30 when driving the stent distally, and (b) fold inwardly (due, at least in part, to flex slot 48 of the stent-engaging element) and slide proximally within the stent's lumen.



FIG. 8 provides a schematic depiction of the stent advancement process. Distal end 31 of stent 30 has exited outer sheath 20 and has expanded. Element 40 moves proximally and distally, as indicated by arrows. As stent-engaging element 45 travels distally, it engages and advances stent 30, thus driving it out of outer sheath 20. No advancement of stent 30 occurs when stent-engaging element 45 travels proximally due to the shape of stent-engaging element 45. Instead, the configuration of stent-engaging element 45 enables it to bend inwardly as it moves over and encounters portions (e.g., wire portions) of stent 30 during the proximal movement of user-actuatable element 50 without disturbing the axial position of the stent relative to the outer sheath. Preferably, advancement of stent 30 is achieved without a mechanized concomittant withdrawal of outer sheath 20 and without motion of outer sheath 20 relative to device body 90 (aside from incidental motion caused by patient's body movements, vibrations, etc.).



FIGS. 9-10 illustrate schematically stent deployment in a body vessel. FIG. 9 depicts stent 30 in a constrained, or elongated, configuration. This is an example of a configuration of stent 30 when it is within outer sheath 20 of device 10. FIG. 10 shows stent 30 in an expanded state in body vessel 160, which is one state a self-expanding stent may take when it exits outer sheath 20.


In some embodiments, the present devices may also include a stent-retention element configured to allow an operator to re-sheath the stent during the advancement and/or deployment process, provided the stent has not been advanced completely out of the sheath. Referring to FIGS. 11 and 12A, device 10 includes stent-retention element 70 coupled to proximal end 32 of stent 30. In a preferred embodiment, contact between distal portion 71 of stent-retention element 70 and stent 30 exists as long as proximal end 32 of stent 30 is within outer sheath 20, even during proximal movement of stent-engaging element 45. When proximal end 32 of stent 30 is advanced outside of outer sheath 20, stent 30 expands to a radius larger than the greatest width (taken in the radial direction shown in the figures) of distal portion 71 of stent-retention element 70. As a result, contact between stent 30 and stent-retention element 70 ceases, and deployment of stent 30 is completed. Accordingly, stent-retention element 70 is operable to withdraw stent 30 proximally back into outer sheath 20 (through action by an operator) provided that a proximal portion of stent 30 (specifically, the proximal portion coupled to stent-retention element 70) is disposed within outer sheath 20.


Referring to FIGS. 2A, 3A and 11-12, proximal portion 72 (also visible in FIG. 3B) of stent-retention element 70 is a cable or similar device that facilitates withdrawal of stent 30 proximally back into outer sheath 20 and that may be characterized as a stent-retention line, provided that a proximal portion of stent 30 is disposed within outer sheath 20. Distal portion 71 of stent-retention element 70 may be a piece of tubing (such as hypotube) that is provided with multiple, radially-projecting prongs 73 that engage openings in woven versions of stent 30. The tubing may be coupled in any suitable fashion (such as through soldering) to proximal portion 72.


As shown in FIGS. 1 and 2A, Y-adapter 95 may be coupled to the proximal portion of device body 90. Inner tube 60 may be placed through straight arm 96 and proximal portion 72 may be placed through angled arm 97 of Y-adapter 95. As shown in FIG. 2B, a stent-retention element position marker 93 may be coupled to line 72 and positioned along the line to the relative position of the stent that is coupled to the stent-retention element. For example, the marker, which may be a piece of heat shrink tubing, may be positioned along the line such that when it extends into the perimeter of angled arm 97 the stent will completely exit outer sheath 20. In this way, an operator has a visual indicator that conveys how far the stent has exited the outer sheath. FIGS. 1 and 2A also show that the stent-retention element may include a finger element 98 coupled to line 72 in any suitable manner (e.g., though LOCTITE® adhesive), to provide a user with something to hold to enable manipulation of the stent-retention element. FIG. 12B shows a preferred embodiment of stent-retention element 70, which finger element 98 in cross-section and showing an example connection location 99 (for adhesive or the like) between line 72 and finger element 98 (which may have inner and outer components, as shown, that are threaded together).


Preferably, device 10 comprises side port 110 (coupled to device body 90) and Luer fitting 100 (coupled to proximal end 62 of inner tube 60) to allow for flushing of outer sheath 20 and inner tube 60, respectively. The flushing may be with saline and may occur prior to a procedure. Alternate embodiments of the present devices may include alternate designs for flushing outer sheath 20 and inner tube 60, or may not be configured to allow for flushing. FIG. 3D is a top view of device 10 and identifies a cutaway detail near the distal end of device body 90 that is shown in greater detail in FIG. 3E.


Referring to FIG. 2C, second position 122 of stopper 120 allows user-actuatable element 50 to travel distally the full length of slot 52. The distal-most position of user-actuatable element 50 corresponds to a position where stent-engaging element 45 is outside (distal to) outer sheath 20, and therefore in a region where stent 30 will be driven out of outer sheath 20 and in its expanded state. A stent in this position that is de-coupled from distal portion 71 of stent-retention element 70 can no longer be withdrawn into outer sheath 20. Furthermore, a stent in an expanded condition will have radial clearance over stent-engaging element 45. Alternate embodiments of the present devices may employ other designs to limit the travel of user-actuatable element 50, or have no adjustable travel-limiting feature.



FIGS. 13-14 depict another embodiment of the present devices that includes capture device 80 coupled to proximal portion 72 of stent-retention element 70. Capture device 80 serves to release appropriate amounts of proximal portion 72 as stent-engaging element 45 advances stent 30. Capture device 80 includes a stop that serves to halt distal advancement of stent 30 prior to full deployment of stent 30 from outer sheath 20. The stop (which can be a piece of tubing, such as hypotube, that is coupled at an appropriate location to proximal portion 72) provides operator feedback at the point where further advancement would result in stent deployment (thus, the stop can be used as an indicator of the location at which stent withdrawal will no longer be possible). Here, the operator may choose to withdraw stent 30 into outer sheath 20 for repositioning by pulling proximally on stent-retention element 70, or proceed with stent deployment by depressing deployment stop lever 81 (which allows the stop to bypass the deployment stop lever and permits continued distal advancement of the stent-retention element) and continuing with advancement via user-actuatable element 50.


If the operator chooses to withdraw stent 30 into outer sheath 20 for repositioning, the operator can actuate retention pull lever 84, which (in the depicted embodiment) de-couples capture device 80 from device body 90 and allows the operator to proceed with drawing stent 30 by pulling proximal portion 72 of stent-retention element 70 proximally. After withdrawal of stent 30 into outer sheath 20, retention pulley 82 and spring 83 of capture device 80 operate to accumulate excess slack of stent-retention element 70. In this embodiment, proximal portion 72 of stent-retention element 70 may be threaded through a portion of device body 90 that is not centrally disposed within the device body. Alternate embodiments of the present devices that include capture devices may include capture devices that are configured differently from capture device 80, such as automated capture devices. Furthermore, capture device 80 may be coupled to angled arm 97 in the embodiment of device 10 shown in FIG. 1, in place of finger element 98.


The present devices may be disposable and packaged in a bag, pouch, box, or other suitable container, after having been sterilized using any suitable technique, such as sterilization using ethylene oxide gas. There may be a small gap between the distal end of the outer sheath and the proximal end of the nose cone to allow for the sterilizing gas to flow throughout the device. The container may include instructions for using the device that are printed on the container or included inside the container. After the device is removed from its container, saline may be used to flush the outer sheath and its contents and the inner tube. The gap between the nose cone and the outer sheath can then be closed by pulling proximally on the inner tube to which the nose cone is coupled. If the procedure involves stenting a blood vessel, any suitable technique for positioning the device in the appropriate location may be used (e.g, such as the Seldinger technique). The nose cone of the device (which may be any suitable flexible tip) may be radio opaque and may represent a distal-most marker for the device. Another radio opaque marker made from any suitable material (such as a platinum band, or a band made from any suitable platinum alloy) may be coupled to a portion of the device that is proximal to the nose cone, such as to the outer sheath (as discussed above), element 40, or the inner element, to create a proximal-most marker for the device. These two markers may be used by the operator to position the device relative to the lesion of interest to enable accurate deployment of the stent.


The present methods include stent advancement methods for distally driving a stent out of a sheath (e.g., outer sheath 20) and into a tubular structure. In some embodiments, the tubular structure is animal tissue (such as a human blood vessel). In other embodiments, the tubular structure is not animal tissue and comprises a polymer structure that can be used to test a given device technique or demonstrate stent advancement to one or more persons, such as a doctor considering using the device or stent advancement technique in his or her practice.


Some embodiments of the present stent advancement methods include distally driving a stent (e.g., stent 30) out of a sheath (e.g., outer sheath 20) and into a tubular structure by repeatedly engaging the stent between its distal and proximal ends with a stent-engaging element (e.g., stent-engaging element 45), where at least two of the engagements are separated by a period of non-engagement; and as the stent is distally driven out of the sheath, varying the axial density of the stent within the tubular structure by varying the axial position of the sheath relative to the tubular structure. As the stent is driven distally out of the sheath, the remainder of the device is withdrawn proximally by the operator relative to the tubular structure so that the deployed portion of the stent remains stationary relative to the tubular structure (e.g., human tissue) into which it is deployed. The rate at which the remainder of the device is withdrawn may be varied to vary the axial density of the stent: a slower withdrawal rate increases the axial density of the stent, whereas a faster rate decreases the axial density of the stent. It may be desirable to increase the axial density of the stent in, for example, a location where a greater hoop strength is required to maintain the patency of the tubular structure, such as along a stenosed region 210 of an artery 200 as shown in FIG. 15A. It may be desirable to decrease the axial density of the stent in, for example, a location where fluid flow into a section of the stent from the side is anticipated or desired, or at the location of penetration of a second stent, either of which may be true at an anatomical side branch 260 of a vessel 250 as shown in FIG. 15B.


Some embodiments of the present stent advancement methods include distally driving a stent (e.g., stent 30) out of a sheath (e.g., outer sheath 20) and into a tubular structure by repeatedly engaging the stent between its distal and proximal ends with a stent-engaging element (e.g., stent-engaging element 45), where at least two of the engagements are separated by a period of non-engagement; and engaging the stent at its proximal end with a stent-retention element (e.g., stent-retention element 70) that is positioned within the sheath.


In some embodiments, the engagements that drive the stent distally from the sheath may be achieved using a device that is configured to not mechanically concomittantly withdraw the sheath as the stent is driven distally, such as the versions of the present devices shown in the figures. The tubular structure in those embodiments can be an anatomical tubular structure, such as a vessel or duct, or a tubular structure that is not animal tissue, such as a polymer tube 300 (see FIG. 15C). Regardless, in some embodiments, the method may also include engaging the stent at its proximal end with a stent-retention element that is positioned within the sheath. The stent-retention element may include a stent-retention line, and the method may also include, after the stent is partially-driven out of the sheath, withdrawing the stent back into the sheath by moving the stent-retention line. An operator may accomplish the driving of the stent by moving a user-actuatable element (e.g., user-actuatable element 50) with the operator's thumb. The stent may be woven, a stent-engaging element may engage multiple wire intersections of the stent and move distally during the engagements that drive the stent, and the stent-engaging element may slide proximally within the stent's lumen during the period of non-engagement.


Some of the present methods are methods of instructing another or others on how to advance a stent out of sheath and into a tubular structure. Some embodiments of the present stent advancement instruction methods include instructing a person on how to use a stent delivery device (e.g., device 10) that includes a sheath (e.g., outer sheath 20) and a stent (e.g., stent 30) disposed in the sheath. The instructing may include demonstrating the following steps to the person: distally driving the stent out of the sheath and into a tubular structure by repeatedly engaging the stent between its distal and proximal ends with a stent-engaging element (e.g., stent-engaging element 45), where at least two of the engagements are separated by a period of non-engagement; and, as the stent is distally driven out of the sheath, varying the axial density of the stent within the tubular structure by varying the axial position of the sheath relative to the tubular structure.


Some embodiments of the present stent advancement instruction methods include instructing a person on how to use a stent delivery device (e.g., device 10) that includes a sheath (e.g., outer sheath 20) and a stent (e.g., stent 30) disposed in the sheath. The instructing may include demonstrating the following steps to the person: distally driving the stent out of the sheath and into a tubular structure by repeatedly engaging the stent between its distal and proximal ends with a stent-engaging element (e.g., stent-engaging element 45), where at least two of the engagements are separated by a period of non-engagement; and engaging the stent at its proximal end with a stent-retention element (e.g., stent-retention element 70) that is positioned within the sheath.


The instruction methods may be accomplished in some embodiments by a live demonstration in the presence of the person and in other embodiments by a recorded or simulated demonstration that is played for the person. An example of a recorded demonstration is one that was carried out by a person and captured on camera. An example of a simulated demonstration is one that did not actually occur, and that instead was generated using a computer system and a graphics program. In the case of a recorded or simulated demonstration, the demonstration may exist in any suitable form—such as a on DVD or in any suitable video file (such as an mpg, .mov., .qt, .rm, .swf, or .wmv file)—and the instructing may be accomplished by playing the demonstration for the viewer using any suitable computer system. The viewer or viewers may cause the demonstration to play. For example, the viewer may access the recorded or simulated demonstration file using the internet, or any suitable computer system that provides the viewer with access to the file. See FIG. 16.


In embodiments of the present methods that involve stent delivery into an anatomical structure, and the device used to accomplish the method is in a desired location within a patient to start the stent advancement, the movement (e.g, the ratcheting movement) of the stent-engagement element can begin such that the distal end of the stent (which can also be provided with one or more radio opaque markers to enable easier viewing of its position during the procedure) exits the outer sheath of the device, but not to such an extent that it expands to contact the anatomical structure. If the distal end of the stent is proximal of where the operator wants it, and a stent-retention element is used, the stent-retention element can be pulled proximally to resheath the stent and reposition the device; if the stent is distal of where the operator wants it, the entire device can be withdrawn proximally and the deployment process continued.


The different features of the present devices can be made from commercially-available, medical-grade materials. For example, nose cone 150 may be made from a polyether block amide (such as PEBAX® resin, available from Arkema Inc, Philadelphia, Pa.). A distal portion of inner element 60 (such as inner sleeve 61) may be made from polyimide and coupled to a more proximal portion made from stainless steel hypotube (such as 304 or 316L stainless steel). Luer fitting 100 coupled to inner element 60 (e.g., outer sleeve 63) may be made from polycarbonate. Outer sheath 20 may be made from a braided polyether block amide (e.g, a braided PEBAX® resin). Device body 90, user-actuatable element 50, block 51, and stopper 120 may be made from ABS (acrylonitrile butadiene styrene) plastic, polycarbonate, or DELRIN® acetal resin (available from DuPont). Stopper 120 may be coupled to a stainless steel spring that biases it as described above. Element 40 may have a shaft formed from polyimide (or, a series of shafts, as in the preferred embodiment, that are made from polyimide or nitinol hypotube), and stent-engaging element 45 may include or be coupled to a short piece of nitinol hypotube (e.g., tube 46) coupled to the polyimide shaft with a suitable adhesive (e.g, LOCTITE® adhesive, which includes cyanoacrylates) and a piece of nitinol hypotube fashioned in the desired shape and welded (e.g, laser welded) to the short piece of nitinol hypotube. Stent-retention element 70 may include an intertwined stainless steel wire (used as proximal portion 72) that is covered with a material such as nylon, FEP (fluorinated ethylene propylene) tubing, or PET (polyester) tubing, and distal portion 71 may be made from stainless steel hypotube. Furthermore, steps may be taken to reduce the friction between the parts that contact or may contact either other during use of the present devices, such as contact between the stent and the outer sheath.


The present devices may be used to deliver self-expending stents that are woven, including stents woven from multiple strands, such as wires. Some examples of weaving techniques that may be used include those in U.S. Pat. Nos. 6,792,979 and 7,048,014, which are incorporated by reference. The strands of a woven stent may terminate in strand ends (e.g, wire ends) that are then joined together using small segments of material, such as nitinol hypotube, when the stent strands are wires made from nitinol. The stent may be passivated through any suitable technique in order to remove the oxide layer from the stent surface that can be formed during any heat treating and annealing, thus improving the surface finish and corrosion resistance of the stent material. Suitable stent creation techniques for stents that may be used with the present devices (including the strand crossings that may be engaged by stent-engaging element 45) are set forth in U.S. patent application Ser. No. 11/876,666, which is incorporated by reference.


It should be understood that the present devices and methods are not intended to be limited to the particular forms disclosed. Rather, they are to cover all modifications, equivalents, and alternatives falling within the scope of the claims. For example, while the embodiments of the present devices shown in the figures included a stent-engaging element and a user-actuatable element that moved the same distances in response to operator input, other embodiments of the present devices could include gears or other mechanisms that create a ratio between the distance that the user-actuatable element moves and the resulting distance that the stent-engaging element moves that is not 1:1 (such that the reciprocating element distance can be greater or less than the user-actuatable element distance). Furthermore, still other embodiments may employ other structures for achieving periodic engagement of a stent in order to advance it distally, such as a through a squeeze-trigger mechanism similar to the one shown in U.S. Pat. No. 5,968,052, which is incorporated by reference, or in U.S. Pat. No. 6,514,261, which is incorporated by reference, or through a stent-engaging element that rotates rather than translates and that possesses a cam portion configured to engage the stent during part of a given rotation and not engage the stent during another part of that rotation. Furthermore, still other embodiments may employ other forms of reciprocating movement of a stent-engaging element (such as stent-engaging element 45), such as through another form of operator input like a rotational user-actuatable input (rather than a translation input, as is shown in the figures) coupled to the stent-engaging element via a cam.


The claims are not to be interpreted as including means-plus- or step-plus-function limitations, unless such a limitation is explicitly recited in a given claim using the phrase(s) “means for” or “step for,” respectively.

Claims
  • 1. A device comprising: an outer sheath;a stent disposed within the outer sheath, the stent having a distal end and a proximal end;a stent-engaging element positioned at least partially within a lumen of the stent; anda stent-retention element configured to contact the proximal end of the stent;a handle coupled to the outer sheath such that the outer sheath cannot move relative to the handle;a user-actuatable element movable along the handle, the user-actuatable element being coupled to the stent-engaging element;a stopper biased to a first position that restricts distal advancement of the user-actuatable element, the stopper comprising a passageway, wherein the stopper has a second position that allows the user-actuatable element to pass through the passageway;wherein the device is configured such that:the stent-engaging element is configured to operate in a reciprocating manner to engage and advance the stent distally at least partially out of the outer sheath; andthe stent-retention element will stay in contact with the stent during proximal movement of the stent-engaging element provided that the proximal end of the stent is disposed within the outer sheath and will cease contact when the proximal end of the stent is advanced outside of the outer sheath.
  • 2. The device of claim 1, wherein the user-actuatable element is coupled to the stent-engaging element by an element having a passageway.
  • 3. The device of claim 2, further comprising: an inner element having a portion positioned within the element having a passageway, the inner element being configured to accept a guidewire.
  • 4. The device of claim 1, where the user-actuatable element is movable within a slot of the handle.
  • 5. The device of claim 1, where the stent has a deployment length, the outer sheath has a distal end, and the device further comprises: a marker coupled to the outer sheath and spaced apart from the outer sheath's distal end by a distance corresponding substantially to the deployment length of the stent.
  • 6. The device of claim 1, further comprising: a side port coupled to the handle.
  • 7. The device of claim 1, further comprising an element that can be coupled to the outside of the outer sheath, the element being configured to interface with a hemostasis valve of an introducer.
  • 8. The device of claim 1, further comprising: a Y-adapter coupled to the handle;where the stent-retention element includes a distal portion and a stent-retention line extending from outside a branch of the Y-adapter and through the branch, the handle, and a portion of the outer sheath to the distal portion of the stent-retention element.
  • 9. The device of claim 1, where the stent is woven, and the stent-engaging element is configured so as to (a) engage wire intersections on opposing sides of the stent when driving the stent distally, and (b) fold inwardly and slide proximally within the stent's lumen.
  • 10. The device of claim 1, wherein the stent-engaging element is shaped like a shovel.
  • 11. The device of claim 1, wherein the stent-engaging element is configured to operate in the reciprocating manner without a mechanized concomitant withdrawal of the outer sheath.
  • 12. The device of claim 1, wherein the stopper in the second position allows the user-actuatable element to travel a full length of a slot.
  • 13. A device comprising: an outer sheath;a handle coupled to the outer sheath such that the outer sheath cannot move relative to the handle, the handle having a proximal end and a user-actuatable element constrained by a length of a slot;a stent disposed within the outer sheath, the stent having a distal end and a proximal end;a stent-engaging element coupled to the user-actuatable element and configured to engage the stent between the distal and proximal ends of the stent; anda stopper comprising a passageway, the stopper biased to a first position that restricts distal advancement of the user-actuatable element, wherein the stopper has a second position that allows the user-actuatable element to pass through the passageway to travel a full length of the slot,wherein distal and proximal movement of the user-actuatable element advances the stent distally out of the outer sheath through multiple engagements of the stent by the stent-engaging element,wherein each engagement occurs between the proximal and distal ends of the stent,wherein distal movement of the user-actuatable element drives the stent distally without a mechanized concomitant withdrawal of the outer sheath, andwherein proximal movement of the user-actuatable element does not drive the stent distally; andthe user's proximal-most point of contact with the device that causes each engagement is located at or distal of the proximal end of the handle.
  • 14. The device of claim 13, wherein the user-actuatable element is coupled to the stent-engaging element by an element having a passageway.
  • 15. The device of claim 14, further comprising: an inner element having a portion positioned within the element having a passageway, the inner element being configured to accept a guidewire.
  • 16. The device of claim 14, further comprising: a side port coupled to the handle.
  • 17. The device of claim 13, where the stent has a deployment length, the outer sheath has a distal end, and the device further comprises: a marker coupled to the outer sheath and spaced apart from the outer sheath's distal end by a distance corresponding substantially to the deployment length of the stent.
  • 18. The device of claim 13, further comprising an element that can be coupled to the outside of the outer sheath, the element being configured to interface with a hemostasis valve of an introducer.
  • 19. The device of claim 13, further comprising: a Y-adapter coupled to the handle; anda stent-retention element coupled to the proximal end of the stent;where the stent-retention element includes a distal portion and a stent-retention line extending from outside a branch of the Y-adapter and through the branch, the handle, and a portion of the outer sheath to the distal portion of the stent-retention element.
  • 20. The device of claim 13, further comprising: a stent-retention element coupled to the proximal end of the stent.
  • 21. The device of claim 13, where the stent is woven, and the stent-engaging element is configured so as to (a) engage wire intersections on opposing sides of the stent when driving the stent distally, and (b) fold inwardly and slide proximally within the stent's lumen.
  • 22. The device of claim 13, wherein the stent-engaging element is shaped like a shovel.
  • 23. A device comprising: an outer sheath;a handle coupled to the outer sheath such that the outer sheath cannot move relative to the handle, the handle having a proximal end;a stent disposed within the outer sheath, the stent having a lumen, a distal end and a proximal end;a stent-engaging element positioned at least partially within the lumen of the stent, the stent-engaging element shaped like a shovel and configured to engage two intersections on opposing sides of the stent when driving the stent distally;a user-actuatable element slidable along a slot of the handle; anda stopper biased to a first position that restricts distal advancement of the user-actuatable element, the stopper comprising a passageway, the user-actuatable element movable along a portion of the slot when the stopper is in the first position, the portion less than a full length of the slot, and movable along the full length of the slot and through the passageway when the stopper is in a second position,where the device is configured such that:a user can advance the stent distally out of the outer sheath through at least two periods of engagement of the stent by the stent-engaging element that drive the stent distally and that are separated by a period of non-engagement that does not drive the stent distally; andthe user's proximal-most point of contact with the device that causes each period of engagement is located at or distal of the proximal end of the handle.
  • 24. The device of claim 23, further comprising: the user-actuatable element also being coupled to the stent-engaging element by an element having a passageway.
  • 25. The device of claim 24, further comprising: an inner element having a portion positioned within the element having a passageway, the inner element being configured to accept a guidewire.
  • 26. The device of claim 23, where the stent has a deployment length, the outer sheath has a distal end, and the device further comprises: a marker coupled to the outer sheath and spaced apart from the outer sheath's distal end by a distance corresponding substantially to the deployment length of the stent.
  • 27. The device of claim 23, further comprising: a side port coupled to the handle.
  • 28. The device of claim 23, further comprising an element that can be coupled to the outside of the outer sheath, the element being configured to interface with a hemostasis valve of an introducer.
  • 29. The device of claim 23, further comprising: a Y-adapter coupled to the handle; anda stent-retention element coupled to the proximal end of the stent;where the stent-retention element includes a distal portion and a stent-retention line extending from outside a branch of the Y-adapter and through the branch, the handle, and a portion of the outer sheath to the distal portion of the stent-retention element.
  • 30. The device of claim 23, further comprising: a stent-retention element coupled to the proximal end of the stent.
  • 31. The device of claim 23, where the stent is woven, and the stent-engaging element is configured so as to fold inwardly and slide proximally within the stent's lumen.
  • 32. The device of claim 23, wherein the shovel stent-engaging element includes a flex slot.
  • 33. The device of claim 23, wherein the device is configured to advance the stent distally out of the outer sheath without a mechanized concomitant withdrawal of the outer sheath.
  • 34. The device of claim 23, wherein the stopper in the second position allows the user-actuatable element to travel a full length of a slot.
  • 35. A device comprising: an outer sheath;a stent disposed within the outer sheath, the stent having a lumen, a distal end and a proximal end;an inner element positioned at least partially within the lumen of the stent, the inner element being configured to accept a guidewire; anda stent-engaging element separate from the inner element and positioned at least partially within the lumen of the stent;a handle coupled to the outer sheath such that the outer sheath cannot move relative to the handle;a user-actuatable element movable along the handle, the user-actuatable element being coupled to the stent-engaging element;a stopper biased to a first position that restricts distal advancement of the user-actuatable element, the stopper comprising a passageway, wherein the stopper has a second position that allows the user-actuatable element to pass through the passageway;wherein the device is configured to distally drive the stent at least partially out of the outer sheath through at least two periods of engagement of the stent by the stent-engaging element that are separated by a period of non-engagement that does not drive the stent distally.
  • 36. The device of claim 35, wherein the user-actuatable element is coupled to the stent-engaging element by an element having a passageway.
  • 37. The device of claim 35, where the user-actuatable element is a movable within a slot of the handle.
  • 38. The device of claim 35, where the stent has a deployment length, the outer sheath has a distal end, and the device further comprises: a marker coupled to the outer sheath and spaced apart from the outer sheath's distal end by a distance corresponding substantially to the deployment length of the stent.
  • 39. The device of claim 35, further comprising: a side port coupled to the handle.
  • 40. The device of claim 35, further comprising an element that can be coupled to the outside of the outer sheath, the element being configured to interface with a hemostasis valve of an introducer.
  • 41. The device of claim 35, further comprising: a Y-adapter coupled to the handle; anda stent-retention element coupled to the proximal end of the stent;where the stent-retention element includes a distal portion and a stent-retention line extending from outside a branch of the Y-adapter and through the branch, the handle, and a portion of the outer sheath to the distal portion of the stent-retention element.
  • 42. The device of claim 35, further comprising: a stent-retention element coupled to the proximal end of the stent.
  • 43. The device of claim 35, where the stent-engaging element is also configured to fold inwardly and slide proximally within the stent's lumen.
  • 44. The device of claim 35, wherein the device is configured to distally drive the stent at least partially out of the sheath without a mechanized concomitant withdrawal of the outer sheath.
  • 45. The device of claim 35, wherein the stent-engaging element is shaped like a shovel.
  • 46. The device of claim 35, wherein the stent-engaging element is configured to engage two intersections on opposing sides of the stent.
  • 47. The device of claim 35, wherein the stopper in the second position allows the user-actuatable element to travel a full length of a slot.
  • 48. A stent advancement method comprising: distally driving a stent out of a sheath and into a tubular structure by engaging the stent between its distal and proximal ends with a stent-engaging element a multiple number of engagements, wherein the multiple number of engagements are separated by a period of non-engagement, and wherein during each of the multiple number of engagements, the stent-engaging element moves from a first position to a second position distal to the first position; andengaging the stent at its proximal end with a stent-retention element that is positioned within the sheath,wherein an operator accomplishes the driving of the stent by moving a user-actuatable element with the operator's thumb,wherein the user-actuatable element is constrained by a traversable length of a slot, andwherein moving a stopper from a first position to a second position to a second position changes the traversable length of the slot.
  • 49. The stent advancement method of claim 48, where the tubular structure is animal tissue.
  • 50. The stent advancement method of claim 49, where the stent-retention element includes a stent-retention line, and the method further comprises: after the stent is partially-driven out of the sheath, withdrawing the stent back into the sheath by moving the stent-retention line.
  • 51. The stent advancement method of claim 50, where an operator accomplishes the driving of the stent by moving a user-actuatable element with the operator's thumb.
  • 52. The stent advancement method of claim 51, where the stent is woven, the stent-engaging element engages multiple wire intersections of the stent and moves distally during the engagements that drive the stent, and the stent-engaging element slides proximally within the stent's lumen during the period of non-engagement.
  • 53. The stent advancement method of claim 48, where the tubular structure is not part of an animal.
  • 54. The stent advancement method of claim 53, where the stent-retention element includes a stent-retention line, and the method further comprises: after the stent is partially-driven out of the sheath, withdrawing the stent back into the sheath by moving the stent-retention line.
  • 55. The stent advancement method of claim 48, where the stent is woven, the stent-engaging element engages multiple wire intersections of the stent and moves distally during the engagements that drive the stent, and the stent-engaging element slides proximally within the stent's lumen during the period of non-engagement.
  • 56. The stent advancement method of claim 48, wherein distally driving the stent out of the sheath occurs without a mechanized concomitant withdrawal of the outer sheath.
  • 57. The stent advancement method of claim 48, wherein, during the period of non-engagement, the stent-engagement element folds inwardly and slides proximally.
  • 58. The stent advancement of claim 48, wherein, during the multiple number of engagements, the stent-engaging element engages two intersections on opposing sides of the stent.
  • 59. The stent advancement method of claim 48, wherein the stent-engagement element is shaped like a shovel.
  • 60. A device comprising: an outer sheath;a handle coupled to the outer sheath, the outer sheath being stationary relative to the handle, the handle including a user-actuatable element coupled to a pusher, the user-actuatable element movable along a slot of the handle;a stopper comprising a passageway, the stopper rotatable from a first position in which the passageway is not aligned with the slot to a second position in which the passageway is aligned with the slot;a stent disposed within the outer sheath; anda stent-engaging element disposed within the outer sheath and coupled to the pusher;wherein the stent is distally driveable out of the outer sheath through at least two periods of engagement of the stent by the stent-engaging element, each said period of engagement configured to drive the stent distally without a mechanized concomitant withdrawal of the outer sheath and each said period of engagement separated by a period of non-engagement of the stent by the stent-engaging element that is configured to not drive the stent distally.
  • 61. The device of claim 60, wherein the stent has a distal end, a proximal end, and a lumen extending between the distal end and the proximal end, and wherein the stent-engaging element is positioned at least partially within the lumen of the stent.
  • 62. The device of claim 60, wherein the pusher includes a passageway.
  • 63. The device of claim 62, wherein the passageway is configured to accept a guidewire.
  • 64. The device of claim 60, wherein, in the second position, the stopper allows the user-actuatable element to travel a full length of a slot and wherein the stopper is biased in the first position.
  • 65. The device of claim 60, wherein the stent has a proximal end and wherein the device further comprises a stent-retention element engaging the proximal end of the stent while the proximal end of the stent is in the outer sheath.
  • 66. The device of claim 60, wherein the stent comprises a plurality of woven wires.
  • 67. The device of claim 66, wherein the stent-engaging element is configured to (a) engage wire intersections during each said period of engagement, and (b) fold inwardly and slide proximally during each said period of non-engagement.
  • 68. The device of claim 60, wherein the handle has a proximal end and wherein a proximal-most point of contact of a user with the device that causes each said period of engagement is located at or distal of the proximal end of the handle.
  • 69. The device of claim 60, wherein the stent-engaging element is shaped like a shovel or scoop.
  • 70. A stent advancement method comprising: moving a user-actuatable element from a first position in a slot of a handle to a second position in the slot of the handle, the user-actuatable element coupled to a stent-engaging element, wherein during moving the user-actuatable element from the first position to the second position, the stent-engaging element engages a stent between distal and proximal ends of the stent to distally drive a first portion of the stent out of a sheath while a second portion of the stent remains within the sheath;after moving the user-actuatable element from the first position to the second position, moving the user-actuatable element from the second position to the first position, wherein during moving the user-actuatable element from the second position to the first position, the stent-engaging element folds inwardly and slides proximally within the stent;after moving the user-actuatable element from the second position to the first position, second moving the user-actuatable element from the first position to the second position, wherein during second moving the user-actuatable element from the first position to the second position, the stent-engaging element engages the stent between the distal and proximal ends of the stent to drive the second portion of the stent at least partially out of the sheath;after second moving the user-actuatable element from the first position to the second position, rotating a stopper to increase a traversable length of the slot of the handle by the user-actuatable element; andmoving the user-actuatable element to a third position distal to the second position, wherein during moving the user-actuatable element to the third position, the stent-engaging element extends out of the sheath.
  • 71. The method of claim 70, wherein moving the user-actuatable element from the first position to the second position occurs without a mechanized concomitant withdrawal of an outer sheath.
  • 72. The method of claim 70, wherein the user-actuatable element is biased toward the second position in the slot of the handle.
  • 73. The method of claim 70, further comprising engaging a proximal end of the stent with a stent-retention element.
  • 74. The method of claim 70, wherein the stent is woven and the stent-engaging element is configured to engage two intersections on opposing sides of the stent.
  • 75. The method of claim 70, wherein the stent-engaging element is shaped like a shovel.
CROSS-REFERENCE(S) TO RELATED APPLICATION(S)

This application claims priority to U.S. Provisional Patent Application Ser. No. 60/862,456, filed Oct. 22, 2006, the entire contents of which are expressly incorporated by reference.

US Referenced Citations (677)
Number Name Date Kind
2836181 Tapp May 1958 A
2936257 Nailler et al. May 1960 A
3463197 Slade Aug 1969 A
3479670 Medell Nov 1969 A
3620218 Schmitt et al. Nov 1971 A
3868956 Alfidi et al. Mar 1975 A
4503569 Dotter Mar 1985 A
4580568 Gianturco Apr 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4665906 Jervis May 1987 A
4733665 Palmaz Mar 1988 A
4739762 Palmaz Apr 1988 A
4768507 Fischell et al. Sep 1988 A
4771773 Kropf Sep 1988 A
4776337 Palmaz Oct 1988 A
4850999 Planck Jul 1989 A
4877030 Beck et al. Oct 1989 A
4922905 Strecker May 1990 A
4950227 Savin et al. Aug 1990 A
4954126 Wallsten Sep 1990 A
4960410 Pinchuk Oct 1990 A
4969458 Wiktor Nov 1990 A
4990151 Wallsten Feb 1991 A
4994071 MacGregor Feb 1991 A
4997440 Dumican Mar 1991 A
5015253 MacGregor May 1991 A
5019085 Hillstead May 1991 A
5019090 Pinchuk May 1991 A
5026377 Burton et al. Jun 1991 A
5059211 Stack et al. Oct 1991 A
5064435 Porter Nov 1991 A
5067957 Jervis Nov 1991 A
5102417 Palmaz Apr 1992 A
5104404 Wolff Apr 1992 A
5107852 Davidson et al. Apr 1992 A
5116365 Hillstead May 1992 A
5133732 Wiktor Jul 1992 A
5135536 Hillstead Aug 1992 A
5159920 Condon et al. Nov 1992 A
5171262 MacGregor Dec 1992 A
5180376 Fischell Jan 1993 A
5190546 Jervis Mar 1993 A
5201757 Heyn et al. Apr 1993 A
5201901 Harada et al. Apr 1993 A
5211658 Clouse May 1993 A
5219355 Parodi et al. Jun 1993 A
5246445 Yachia et al. Sep 1993 A
5256158 Tolkoff et al. Oct 1993 A
5261916 Engelson Nov 1993 A
5282823 Schwartz et al. Feb 1994 A
5304220 Maginot Apr 1994 A
5306286 Stack et al. Apr 1994 A
5342387 Summers Aug 1994 A
5350398 Pavcnik et al. Sep 1994 A
5360443 Barone et al. Nov 1994 A
5366504 Andersen et al. Nov 1994 A
5372600 Beyar et al. Dec 1994 A
5376077 Gomringer Dec 1994 A
5382259 Phelps et al. Jan 1995 A
5389106 Tower Feb 1995 A
5391172 Williams et al. Feb 1995 A
5395390 Simon et al. Mar 1995 A
5405377 Cragg Apr 1995 A
5405378 Strecker Apr 1995 A
5411507 Heckele May 1995 A
5411549 Peters May 1995 A
5415664 Pinchuk May 1995 A
5419231 Earle, III et al. May 1995 A
D359802 Fontaine Jun 1995 S
5425739 Jessen Jun 1995 A
5425984 Kennedy et al. Jun 1995 A
5433723 Lindenberg et al. Jul 1995 A
5433729 Adams et al. Jul 1995 A
5443458 Eury Aug 1995 A
5454795 Samson Oct 1995 A
5458615 Klemm et al. Oct 1995 A
5464408 Duc Nov 1995 A
5474563 Myler et al. Dec 1995 A
5476508 Amstrup Dec 1995 A
5478355 Muth et al. Dec 1995 A
5480423 Ravenscroft et al. Jan 1996 A
5484425 Fischell et al. Jan 1996 A
5484444 Braunschweiler et al. Jan 1996 A
5496277 Termin et al. Mar 1996 A
5507769 Marin et al. Apr 1996 A
5527282 Segal Jun 1996 A
5527324 Krantz et al. Jun 1996 A
5527337 Stack et al. Jun 1996 A
5534007 St. Germain et al. Jul 1996 A
5534287 Lukic Jul 1996 A
5536274 Neuss Jul 1996 A
5551954 Buscemi et al. Sep 1996 A
5554181 Das Sep 1996 A
5571167 Maginot Nov 1996 A
5571168 Toro Nov 1996 A
5573520 Schwartz et al. Nov 1996 A
5575817 Martin Nov 1996 A
5575818 Pinchuk Nov 1996 A
5591172 Bachmann et al. Jan 1997 A
5591195 Taheri et al. Jan 1997 A
5591199 Porter et al. Jan 1997 A
5591222 Susawa et al. Jan 1997 A
5597378 Jervis Jan 1997 A
5603698 Roberts et al. Feb 1997 A
5607445 Summers Mar 1997 A
5607466 Imbert et al. Mar 1997 A
5609627 Goicoechea et al. Mar 1997 A
5628754 Shevlin et al. May 1997 A
5628787 Mayer May 1997 A
5629077 Turnland et al. May 1997 A
5630840 Mayer May 1997 A
5632771 Boatman et al. May 1997 A
5643339 Kavteladze et al. Jul 1997 A
5645558 Horton Jul 1997 A
5645559 Hachtman et al. Jul 1997 A
5653684 Laptewicz et al. Aug 1997 A
5653727 Wiktor Aug 1997 A
5662703 Yurek et al. Sep 1997 A
5662713 Andersen et al. Sep 1997 A
5667523 Bynon et al. Sep 1997 A
5669880 Solar Sep 1997 A
5669924 Shaknovich Sep 1997 A
5669936 Lazarus Sep 1997 A
5670161 Healy et al. Sep 1997 A
5674276 Andersen et al. Oct 1997 A
5674277 Freitag Oct 1997 A
5679400 Tuch Oct 1997 A
5679470 Mayer Oct 1997 A
5683411 Kavteladze et al. Nov 1997 A
5683450 Goicoechea et al. Nov 1997 A
5683451 Lenker et al. Nov 1997 A
5693086 Goicoechea et al. Dec 1997 A
5695469 Segal Dec 1997 A
5695483 Samson Dec 1997 A
5699880 Hockley Dec 1997 A
5700269 Pinchuk et al. Dec 1997 A
5702373 Samson Dec 1997 A
5702418 Ravenscroft Dec 1997 A
5707376 Kavteladze et al. Jan 1998 A
5709701 Parodi Jan 1998 A
5709703 Lukic et al. Jan 1998 A
5713917 Leonhardt et al. Feb 1998 A
5713948 Uflacker Feb 1998 A
5716365 Goicoechea et al. Feb 1998 A
5716396 Williams, Jr. Feb 1998 A
5718159 Thompson Feb 1998 A
5718724 Goicoechea et al. Feb 1998 A
5720735 Dorros Feb 1998 A
5725571 Imbert et al. Mar 1998 A
5725572 Lam et al. Mar 1998 A
5728150 McDonald et al. Mar 1998 A
5728158 Lau et al. Mar 1998 A
5733267 Del Toro Mar 1998 A
5733327 Igaki et al. Mar 1998 A
5741325 Chaikof et al. Apr 1998 A
5741333 Frid Apr 1998 A
5749880 Banas et al. May 1998 A
5749921 Lenker et al. May 1998 A
5755708 Segal May 1998 A
5758562 Thompson Jun 1998 A
5759186 Bachmann et al. Jun 1998 A
5766204 Porter et al. Jun 1998 A
5766219 Horton Jun 1998 A
5766237 Cragg Jun 1998 A
5766710 Turnlund et al. Jun 1998 A
5769882 Fogarty et al. Jun 1998 A
5772668 Summers et al. Jun 1998 A
5776142 Gunderson Jul 1998 A
5776180 Goicoechea et al. Jul 1998 A
5792156 Perouse Aug 1998 A
5797952 Klein Aug 1998 A
5800508 Goicoechea et al. Sep 1998 A
5800511 Mayer Sep 1998 A
5807398 Shaknovich Sep 1998 A
5824041 Lenker et al. Oct 1998 A
5824053 Khosravi et al. Oct 1998 A
5824058 Ravenscroft et al. Oct 1998 A
5824077 Mayer Oct 1998 A
5830229 Konya et al. Nov 1998 A
5836966 St. Germain Nov 1998 A
RE35988 Winston et al. Dec 1998 E
5843168 Dang Dec 1998 A
5849037 Frid Dec 1998 A
5851217 Wolff et al. Dec 1998 A
5860998 Robinson et al. Jan 1999 A
5876386 Samson Mar 1999 A
5876432 Lau et al. Mar 1999 A
5888201 Stinson et al. Mar 1999 A
5891191 Stinson Apr 1999 A
5902332 Schatz May 1999 A
5911731 Pham et al. Jun 1999 A
5913896 Boyle et al. Jun 1999 A
5916196 Andrea et al. Jun 1999 A
5916263 Goicoechea et al. Jun 1999 A
5928279 Shannon et al. Jul 1999 A
5928280 Hansen et al. Jul 1999 A
5931842 Goldsteen et al. Aug 1999 A
5938696 Goicoechea et al. Aug 1999 A
5941908 Goldsteen et al. Aug 1999 A
5944738 Amplatz et al. Aug 1999 A
5954729 Bachmann et al. Sep 1999 A
5954764 Parodi Sep 1999 A
5964771 Beyar et al. Oct 1999 A
5968052 Sullivan, III et al. Oct 1999 A
5968088 Hansen et al. Oct 1999 A
5972017 Berg et al. Oct 1999 A
5976155 Foreman et al. Nov 1999 A
5976178 Goldsteen et al. Nov 1999 A
5989276 Houser et al. Nov 1999 A
6004348 Banas et al. Dec 1999 A
6007574 Pulnev et al. Dec 1999 A
6015424 Rosenbluth et al. Jan 2000 A
6017319 Jacobsen et al. Jan 2000 A
6019778 Wilson et al. Feb 2000 A
6019785 Strecker Feb 2000 A
6019786 Thompson Feb 2000 A
6024763 Lenker et al. Feb 2000 A
6027529 Roychowdhury et al. Feb 2000 A
6036702 Bachinski et al. Mar 2000 A
6039755 Edwin et al. Mar 2000 A
6042588 Munsinger et al. Mar 2000 A
6042589 Marianne Mar 2000 A
6042605 Martin et al. Mar 2000 A
6048338 Larson et al. Apr 2000 A
6051020 Goicoechea et al. Apr 2000 A
6053943 Edwin et al. Apr 2000 A
6059752 Segal May 2000 A
6063113 Kavteladze et al. May 2000 A
6077295 Limon et al. Jun 2000 A
6080191 Summers Jun 2000 A
6090115 Beyar et al. Jul 2000 A
6090125 Horton Jul 2000 A
6102890 Stivland et al. Aug 2000 A
6102932 Kurz Aug 2000 A
6117167 Goicoechea et al. Sep 2000 A
6120432 Sullivan et al. Sep 2000 A
6120522 Vrba et al. Sep 2000 A
6123115 Greenhalgh Sep 2000 A
6123723 Kónya et al. Sep 2000 A
6124523 Banas et al. Sep 2000 A
6126685 Lenker et al. Oct 2000 A
6136007 Goldsteen et al. Oct 2000 A
6146415 Fitz Nov 2000 A
6149681 Houser et al. Nov 2000 A
6152945 Bachinski et al. Nov 2000 A
6156062 McGuinness Dec 2000 A
6159239 Greenhalgh Dec 2000 A
6164339 Greenhalgh Dec 2000 A
6165213 Goicoechea et al. Dec 2000 A
6168622 Mazzocchi Jan 2001 B1
6171326 Ferrera et al. Jan 2001 B1
6172617 Bullock Jan 2001 B1
6183508 Stinson et al. Feb 2001 B1
6186942 Sullivan et al. Feb 2001 B1
6192944 Greenhalgh Feb 2001 B1
6206912 Goldsteen et al. Mar 2001 B1
6237460 Frid May 2001 B1
6238402 Sullivan, III et al. May 2001 B1
6238430 Klumb et al. May 2001 B1
6241757 An et al. Jun 2001 B1
6245103 Stinson Jun 2001 B1
6248112 Gambale et al. Jun 2001 B1
6248122 Klumb et al. Jun 2001 B1
6251132 Ravenscroft et al. Jun 2001 B1
6258080 Samson Jul 2001 B1
6261315 St. Germain et al. Jul 2001 B1
6264684 Banas et al. Jul 2001 B1
6264689 Colgan et al. Jul 2001 B1
6270521 Fischell et al. Aug 2001 B1
6280467 Leonhardt Aug 2001 B1
6293955 Houser et al. Sep 2001 B1
6293965 Berg et al. Sep 2001 B1
6295714 Roychowdhury et al. Oct 2001 B1
6296622 Kurz et al. Oct 2001 B1
6302893 Limon et al. Oct 2001 B1
6302905 Goldsteen et al. Oct 2001 B1
6302906 Goicoechea et al. Oct 2001 B1
6306105 Rooney et al. Oct 2001 B1
6306141 Jervis Oct 2001 B1
6309415 Pulnev et al. Oct 2001 B1
6312454 Stockel et al. Nov 2001 B1
6319267 Kurz Nov 2001 B1
6325822 Chouinard et al. Dec 2001 B1
6331184 Abrams Dec 2001 B1
6336938 Kavteladze et al. Jan 2002 B1
6342068 Thompson Jan 2002 B1
6346118 Baker et al. Feb 2002 B1
6348048 Andrea et al. Feb 2002 B1
6350278 Lenker et al. Feb 2002 B1
6352531 O'Connor et al. Mar 2002 B1
6355060 Lenker et al. Mar 2002 B1
6361637 Martin et al. Mar 2002 B2
6371953 Beyar et al. Apr 2002 B1
6371979 Beyar et al. Apr 2002 B1
6379365 Diaz Apr 2002 B1
6383214 Banas et al. May 2002 B1
6383216 Kavteladze et al. May 2002 B1
6391051 Sullivan, III et al. May 2002 B2
6398802 Yee Jun 2002 B1
6398803 Layne et al. Jun 2002 B1
6409750 Hyodoh et al. Jun 2002 B1
6419694 Sandock Jul 2002 B1
6423085 Murayama et al. Jul 2002 B1
6425898 Wilson et al. Jul 2002 B1
6440161 Madrid et al. Aug 2002 B1
6447522 Gambale et al. Sep 2002 B2
6451025 Jervis Sep 2002 B1
6451033 Berg et al. Sep 2002 B1
6451047 McCrea et al. Sep 2002 B2
6451052 Burmeister et al. Sep 2002 B1
6468301 Amplatz et al. Oct 2002 B1
6475184 Wang et al. Nov 2002 B1
6475209 Larson et al. Nov 2002 B1
6488700 Klumb et al. Dec 2002 B2
6506204 Mazzocchi Jan 2003 B2
6514196 Sullivan et al. Feb 2003 B1
6514261 Randall et al. Feb 2003 B1
6520983 Colgan et al. Feb 2003 B1
6520986 Martin et al. Feb 2003 B2
6527802 Mayer Mar 2003 B1
6533805 Jervis Mar 2003 B1
6554798 Mann et al. Apr 2003 B1
6558414 Layne May 2003 B2
6559312 Krauss et al. May 2003 B2
6562064 deBeer May 2003 B1
6572645 Leonhardt Jun 2003 B2
6576006 Limon et al. Jun 2003 B2
6579314 Lombardi et al. Jun 2003 B1
6582461 Burmeister et al. Jun 2003 B1
6585695 Adair et al. Jul 2003 B1
6592617 Thompson Jul 2003 B2
6599296 Gillick et al. Jul 2003 B1
6605102 Mazzocchi et al. Aug 2003 B1
6607551 Sullivan et al. Aug 2003 B1
6613075 Healy et al. Sep 2003 B1
6629981 Bui et al. Oct 2003 B2
6638291 Ferrera et al. Oct 2003 B1
6641608 Pulnev et al. Nov 2003 B1
6645237 Klumb et al. Nov 2003 B2
6652544 Houser et al. Nov 2003 B2
6656212 Ravenscroft et al. Dec 2003 B2
6660030 Shaolian et al. Dec 2003 B2
6673883 Rowan Jan 2004 B1
6679903 Kurz Jan 2004 B2
6689162 Thompson Feb 2004 B1
6695862 Cox et al. Feb 2004 B2
6699273 Langan Mar 2004 B2
6702829 Bachinski et al. Mar 2004 B2
6709379 Brandau et al. Mar 2004 B1
6712835 Mazzocchi et al. Mar 2004 B2
6719934 Stinson Apr 2004 B2
6726712 Raeder-Devens et al. Apr 2004 B1
6730117 Tseng et al. May 2004 B1
6733519 Lashinski et al. May 2004 B2
6736839 Cummings May 2004 B2
6736840 Fischell et al. May 2004 B2
6740077 Brandau et al. May 2004 B1
6740115 Lombardi et al. May 2004 B2
6743219 Dwyer et al. Jun 2004 B1
6749627 Thompson et al. Jun 2004 B2
6755854 Gillick et al. Jun 2004 B2
6758858 McCrea et al. Jul 2004 B2
6770087 Layne et al. Aug 2004 B2
6773446 Dwyer et al. Aug 2004 B1
6776791 Stallings et al. Aug 2004 B1
6790226 Edwin et al. Sep 2004 B2
6792979 Konya et al. Sep 2004 B2
6797217 McCrea et al. Sep 2004 B2
RE38653 Igaki et al. Nov 2004 E
6814750 Kavteladze et al. Nov 2004 B2
6846316 Abrams Jan 2005 B2
RE38711 Igaki et al. Mar 2005 E
6859986 Jackson et al. Mar 2005 B2
6860898 Stack et al. Mar 2005 B2
6866669 Buzzard et al. Mar 2005 B2
6866679 Kusleika Mar 2005 B2
6913618 Denardo et al. Jul 2005 B2
6926732 Derus et al. Aug 2005 B2
6932837 Amplatz et al. Aug 2005 B2
6939352 Buzzard et al. Sep 2005 B2
6942654 Schaefer et al. Sep 2005 B1
6942688 Bartholf et al. Sep 2005 B2
6949103 Mazzocchi et al. Sep 2005 B2
6962597 Goodin Nov 2005 B2
6974472 Hong et al. Dec 2005 B2
6989019 Mazzocchi et al. Jan 2006 B2
6989024 Hebert et al. Jan 2006 B2
6997948 Stinson Feb 2006 B2
7001420 Speck et al. Feb 2006 B2
7018401 Hyodoh et al. Mar 2006 B1
7022133 Yee et al. Apr 2006 B2
7033375 Mazzocchi et al. Apr 2006 B2
7037330 Rivelli, Jr. et al. May 2006 B1
7048014 Hyodoh et al. May 2006 B2
7048752 Mazzocchi et al. May 2006 B2
7052511 Weldon et al. May 2006 B2
7052513 Thompson May 2006 B2
7060150 Banas et al. Jun 2006 B2
7070607 Murayama et al. Jul 2006 B2
7083631 Houser et al. Aug 2006 B2
7083640 Lombardi et al. Aug 2006 B2
7094248 Bachinski et al. Aug 2006 B2
7105016 Shiu et al. Sep 2006 B2
7115141 Menz et al. Oct 2006 B2
7122050 Randall et al. Oct 2006 B2
7137993 Acosta et al. Nov 2006 B2
7147618 Kurz Dec 2006 B2
7147655 Chermoni Dec 2006 B2
7156860 Wallsten Jan 2007 B2
7160323 Pulnev et al. Jan 2007 B2
7172617 Colgan et al. Feb 2007 B2
7175650 Ruetsch Feb 2007 B2
7211095 Bachinski et al. May 2007 B2
7211109 Thompson May 2007 B2
7241308 Andreas et al. Jul 2007 B2
7270668 Andreas et al. Sep 2007 B2
7279005 Stinson Oct 2007 B2
7306756 Edwin et al. Dec 2007 B2
7309349 Jackson et al. Dec 2007 B2
7314481 Karpiel Jan 2008 B2
7316701 Ferrera et al. Jan 2008 B2
7316708 Gordon et al. Jan 2008 B2
7320702 Hammersmark et al. Jan 2008 B2
7326236 Andreas et al. Feb 2008 B2
7329279 Haug et al. Feb 2008 B2
7344514 Shanley Mar 2008 B2
7344558 Lorenzo et al. Mar 2008 B2
7367985 Mazzocchi et al. May 2008 B2
7367986 Mazzocchi et al. May 2008 B2
7367987 Balgobin et al. May 2008 B2
7371250 Mazzocchi et al. May 2008 B2
7371251 Mitelberg et al. May 2008 B2
7371252 Balgobin et al. May 2008 B2
7377932 Mitelberg et al. May 2008 B2
7381219 Salahieh et al. Jun 2008 B2
7387640 Cummings Jun 2008 B2
7396362 Jervis Jul 2008 B2
7402170 McCullagh et al. Jul 2008 B2
7404820 Mazzocchi et al. Jul 2008 B2
7410492 Mazzocchi et al. Aug 2008 B2
7419502 Pulnev et al. Sep 2008 B2
7419503 Pulnev et al. Sep 2008 B2
7442200 Mazzocchi et al. Oct 2008 B2
7445631 Salahieh et al. Nov 2008 B2
7462192 Norton et al. Dec 2008 B2
7468071 Edwin et al. Dec 2008 B2
7491224 Cox et al. Feb 2009 B2
7500989 Solem et al. Mar 2009 B2
7510570 Goicoechea et al. Mar 2009 B1
7517361 Ravenscroft Apr 2009 B1
7520893 Rivelli, Jr. Apr 2009 B2
7527632 Houghton et al. May 2009 B2
7527643 Case et al. May 2009 B2
7534250 Schaeffer et al. May 2009 B2
RE40816 Taylor et al. Jun 2009 E
7550001 Dorn et al. Jun 2009 B2
7550002 Goto et al. Jun 2009 B2
7553322 Dorn et al. Jun 2009 B2
7553323 Perez et al. Jun 2009 B1
7556635 Mazzocchi et al. Jul 2009 B2
7556636 Mazzocchi et al. Jul 2009 B2
7566338 Mazzocchi et al. Jul 2009 B2
7566342 Parker et al. Jul 2009 B2
7572273 Mazzocchi et al. Aug 2009 B2
7578829 Goldsteen et al. Aug 2009 B2
7578830 Kusleika et al. Aug 2009 B2
7578838 Melsheimer Aug 2009 B2
7578899 Edwin et al. Aug 2009 B2
7582101 Jones et al. Sep 2009 B2
7604661 Pavcnik et al. Oct 2009 B2
7608058 Wilson et al. Oct 2009 B2
7608099 Johnson et al. Oct 2009 B2
7611528 Goodson, IV et al. Nov 2009 B2
7621946 Turner et al. Nov 2009 B2
7628803 Pavcnik et al. Dec 2009 B2
7637934 Mangiardi et al. Dec 2009 B2
7655039 Leanna et al. Feb 2010 B2
7666218 Klein et al. Feb 2010 B2
7670355 Mazzocchi et al. Mar 2010 B2
7670356 Mazzocchi et al. Mar 2010 B2
7678130 Mazzocchi et al. Mar 2010 B2
7686815 Mazzocchi et al. Mar 2010 B2
7691124 Balgobin Apr 2010 B2
7695507 Rivelli, Jr. et al. Apr 2010 B2
7717923 Kennedy, II et al. May 2010 B2
7717949 Dorn May 2010 B2
7736386 Pulnev et al. Jun 2010 B2
7748389 Salahieh et al. Jul 2010 B2
7763068 Pulnev et al. Jul 2010 B2
7780720 Goicoechea et al. Aug 2010 B2
7785340 Heidner et al. Aug 2010 B2
7794489 Shumer et al. Sep 2010 B2
7806919 Bloom et al. Oct 2010 B2
20010010007 Bachinski et al. Jul 2001 A1
20010025131 Edwin et al. Sep 2001 A1
20010032010 Sandock Oct 2001 A1
20010049547 Moore Dec 2001 A1
20010051809 Houser et al. Dec 2001 A1
20020019659 Goicoechea et al. Feb 2002 A1
20020022857 Goldsteen et al. Feb 2002 A1
20020087046 Sullivan et al. Jul 2002 A1
20020087181 Goldsteen et al. Jul 2002 A1
20020138095 Mazzocchi et al. Sep 2002 A1
20020151955 Tran et al. Oct 2002 A1
20020169474 Kusleika et al. Nov 2002 A1
20020173810 Bachinski et al. Nov 2002 A1
20030009215 Mayer Jan 2003 A1
20030014062 Houser et al. Jan 2003 A1
20030014063 Houser et al. Jan 2003 A1
20030040771 Hyodoh et al. Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030050686 Raeder-Devens et al. Mar 2003 A1
20030083541 Sullivan et al. May 2003 A1
20030109886 Keegan et al. Jun 2003 A1
20030130721 Martin et al. Jul 2003 A1
20030208263 Burmeister et al. Nov 2003 A1
20030216803 Ledergerber Nov 2003 A1
20040073287 Goicoechea et al. Apr 2004 A1
20040093056 Johnson et al. May 2004 A1
20040098081 Landreville et al. May 2004 A1
20040098115 Goicoechea et al. May 2004 A1
20040106979 Goicoechea et al. Jun 2004 A1
20040117004 Osborne et al. Jun 2004 A1
20040133264 Moore Jul 2004 A1
20040167599 Goicoechea et al. Aug 2004 A1
20040181239 Dorn et al. Sep 2004 A1
20040193179 Nikolchev Sep 2004 A1
20040199240 Dorn Oct 2004 A1
20040230286 Moore et al. Nov 2004 A1
20040236402 Layne et al. Nov 2004 A1
20040267348 Gunderson et al. Dec 2004 A1
20050021123 Dorn et al. Jan 2005 A1
20050059889 Mayer Mar 2005 A1
20050065590 Shelso Mar 2005 A1
20050080475 Andreas et al. Apr 2005 A1
20050085892 Goto et al. Apr 2005 A1
20050090893 Kavteladze et al. Apr 2005 A1
20050113902 Geiser et al. May 2005 A1
20050119690 Mazzocchi et al. Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137687 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137689 Salahieh et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050137692 Haug et al. Jun 2005 A1
20050137694 Haug et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050137696 Salahieh et al. Jun 2005 A1
20050137697 Salahieh et al. Jun 2005 A1
20050137699 Salahieh et al. Jun 2005 A1
20050137701 Salahieh et al. Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050149160 McFerran Jul 2005 A1
20050154439 Gunderson Jul 2005 A1
20050182475 Jen et al. Aug 2005 A1
20050209670 George et al. Sep 2005 A1
20050209671 Ton et al. Sep 2005 A1
20050209672 George et al. Sep 2005 A1
20050209675 Ton et al. Sep 2005 A1
20050209676 Kusleika Sep 2005 A1
20050216051 Mazzocchi et al. Sep 2005 A1
20050246010 Alexander et al. Nov 2005 A1
20050288764 Snow et al. Dec 2005 A1
20060015168 Gunderson Jan 2006 A1
20060036309 Hebert et al. Feb 2006 A1
20060058835 Murayama et al. Mar 2006 A1
20060058865 Case Mar 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060074478 Feller, III Apr 2006 A1
20060100687 Fahey et al. May 2006 A1
20060116750 Hebert et al. Jun 2006 A1
20060136034 Modesitt et al. Jun 2006 A1
20060161195 Goldsteen et al. Jul 2006 A1
20060173524 Salahieh et al. Aug 2006 A1
20060184224 Angel Aug 2006 A1
20060184226 Austin Aug 2006 A1
20060212105 Dorn et al. Sep 2006 A1
20060229714 Lombardi et al. Oct 2006 A1
20060241686 Ferrera et al. Oct 2006 A1
20060253191 Salahieh et al. Nov 2006 A1
20060276873 Sato Dec 2006 A1
20070010876 Salahieh et al. Jan 2007 A1
20070010877 Salahieh et al. Jan 2007 A1
20070021821 Johnson et al. Jan 2007 A1
20070043420 Lostetter Feb 2007 A1
20070083253 Fischell et al. Apr 2007 A1
20070093889 Wu et al. Apr 2007 A1
20070100421 Griffin May 2007 A1
20070106367 Ruetsch May 2007 A1
20070118206 Colgan et al. May 2007 A1
20070118207 Amplatz et al. May 2007 A1
20070118214 Salahieh et al. May 2007 A1
20070156223 Vaughan Jul 2007 A1
20070162103 Case et al. Jul 2007 A1
20070162107 Haug et al. Jul 2007 A1
20070173868 Bachinski et al. Jul 2007 A1
20070198076 Hebert et al. Aug 2007 A1
20070203503 Salahieh et al. Aug 2007 A1
20070203563 Hebert et al. Aug 2007 A1
20070208405 Goodin et al. Sep 2007 A1
20070219612 Andreas et al. Sep 2007 A1
20070219616 Modesitt et al. Sep 2007 A1
20070219617 Saint Sep 2007 A1
20070233224 Leynov et al. Oct 2007 A1
20070244540 Pryor Oct 2007 A1
20070244552 Salahieh et al. Oct 2007 A1
20070250151 Pereira Oct 2007 A1
20070255386 Tenne Nov 2007 A1
20070265697 Goicoechea et al. Nov 2007 A1
20070270930 Schenck Nov 2007 A1
20070270932 Headley et al. Nov 2007 A1
20070270936 Andreas et al. Nov 2007 A1
20070282420 Gunderson Dec 2007 A1
20070293928 Tomlin Dec 2007 A1
20070293929 Aoba et al. Dec 2007 A1
20070299500 Hebert et al. Dec 2007 A1
20070299501 Hebert et al. Dec 2007 A1
20070299502 Hebert et al. Dec 2007 A1
20080004685 Seemann et al. Jan 2008 A1
20080039863 Keegan et al. Feb 2008 A1
20080065147 Mazzocchi et al. Mar 2008 A1
20080071308 Mazzocchi et al. Mar 2008 A1
20080091257 Andreas et al. Apr 2008 A1
20080097572 Sheldon et al. Apr 2008 A1
20080109059 Gordon et al. May 2008 A1
20080125806 Mazzocchi et al. May 2008 A1
20080125849 Burpee et al. May 2008 A1
20080125859 Salahieh et al. May 2008 A1
20080132989 Snow et al. Jun 2008 A1
20080183272 Wood et al. Jul 2008 A1
20080221654 Buiser et al. Sep 2008 A1
20080234795 Snow et al. Sep 2008 A1
20080234796 Dorn Sep 2008 A1
20080234814 Salahieh et al. Sep 2008 A1
20080262591 Shin et al. Oct 2008 A1
20080288043 Kaufmann et al. Nov 2008 A1
20080290076 Sheldon et al. Nov 2008 A1
20080294231 Aguilar et al. Nov 2008 A1
20080300667 Hebert et al. Dec 2008 A1
20090030495 Koch Jan 2009 A1
20090036967 Cummings Feb 2009 A1
20090054969 Salahieh et al. Feb 2009 A1
20090082841 Zacharias et al. Mar 2009 A1
20090099637 Barthold et al. Apr 2009 A1
20090099643 Hyodeh et al. Apr 2009 A1
20090125092 McCrea et al. May 2009 A1
20090143849 Ozawa et al. Jun 2009 A1
20090149936 Lentz Jun 2009 A1
20090157162 Chow et al. Jun 2009 A1
20090171427 Melsheimer et al. Jul 2009 A1
20090177260 Aggerholm Jul 2009 A1
20090177264 Ravenscroft Jul 2009 A1
20090182407 Leanna et al. Jul 2009 A1
20090182410 Case et al. Jul 2009 A1
20090228092 Raeder-Devens et al. Sep 2009 A1
20090234428 Snow et al. Sep 2009 A1
20090234443 Ottma et al. Sep 2009 A1
20090254168 Parker et al. Oct 2009 A1
20090276028 Bailey et al. Nov 2009 A1
20090276030 Kusleika Nov 2009 A1
20090276033 Mayer Nov 2009 A1
20090299449 Styrc Dec 2009 A1
20090299451 Ellsworth et al. Dec 2009 A1
20090299461 Chermoni Dec 2009 A1
20090311132 Banas et al. Dec 2009 A1
20090312829 Aoba et al. Dec 2009 A1
20100004729 Chew et al. Jan 2010 A1
20100004732 Johnson et al. Jan 2010 A1
20100010617 Goodson, IV et al. Jan 2010 A1
20100030320 Feller, IIII Feb 2010 A1
20100042198 Burton Feb 2010 A1
20100042199 Burton Feb 2010 A1
20100057191 Pavcnik et al. Mar 2010 A1
20100094399 Dorn et al. Apr 2010 A1
20100204774 Goodin et al. Aug 2010 A1
20100286756 Dorn et al. Nov 2010 A1
20110295354 Bueche et al. Dec 2011 A1
Foreign Referenced Citations (157)
Number Date Country
2083157 Nov 1991 CA
2173664 Oct 1996 CA
2247891 Sep 1997 CA
2272947 Jun 1998 CA
3618734 Dec 1986 DE
3902364 Aug 1989 DE
4104702 Aug 1992 DE
4235004 Apr 1993 DE
4420142 Dec 1995 DE
68927998 Sep 1997 DE
19703482 Aug 1998 DE
29919625 Jan 2000 DE
69131423 Jan 2000 DE
19910188 May 2000 DE
102005020785 Nov 2006 DE
102006053748 Apr 2008 DE
202010007592 Oct 2010 DE
0145166 Jun 1985 EP
0518839 Dec 1992 EP
0528039 Feb 1993 EP
0686379 Dec 1995 EP
0689807 Jan 1996 EP
0696447 Feb 1996 EP
0701800 Mar 1996 EP
0722700 Jul 1996 EP
0737452 Oct 1996 EP
0740928 Nov 1996 EP
0743047 Nov 1996 EP
0744163 Nov 1996 EP
0744164 Nov 1996 EP
0747021 Dec 1996 EP
0782841 Jul 1997 EP
0788012 Aug 1997 EP
0788802 Aug 1997 EP
0792627 Sep 1997 EP
0804909 Nov 1997 EP
0804934 Nov 1997 EP
0812579 Dec 1997 EP
0857471 Aug 1998 EP
0893108 Jan 1999 EP
0894505 Feb 1999 EP
0941716 Sep 1999 EP
0943302 Sep 1999 EP
0948946 Oct 1999 EP
1010406 Jun 2000 EP
1025813 Aug 2000 EP
1121911 Aug 2001 EP
1208816 May 2002 EP
1221307 Jul 2002 EP
1275352 Jan 2003 EP
1396239 Mar 2004 EP
1402847 Mar 2004 EP
1447058 Aug 2004 EP
1520557 Apr 2005 EP
1582178 Oct 2005 EP
1637092 Mar 2006 EP
1803423 Jul 2007 EP
1834610 Sep 2007 EP
1844739 Oct 2007 EP
1872742 Jan 2008 EP
1900382 Mar 2008 EP
1941845 Jul 2008 EP
2678508 Jan 1993 FR
2735967 Jan 1997 FR
1183497 Mar 1970 GB
1205743 Sep 1970 GB
1565828 Apr 1980 GB
2135585 Sep 1984 GB
59-500652 Apr 1984 JP
07-508199 Sep 1995 JP
09-506540 Jun 1997 JP
09-173469 Jul 1997 JP
09-511160 Nov 1997 JP
09-512460 Dec 1997 JP
10-043313 Feb 1998 JP
10-272190 Oct 1998 JP
11-057021 Mar 1999 JP
11-57021 Mar 1999 JP
2004-510490 Apr 2004 JP
2005-342539 Dec 2005 JP
2006-522649 May 2006 JP
2454205 Jun 2012 RU
1457921 Feb 1989 SU
WO 8303752 Nov 1983 WO
WO 8704935 Aug 1987 WO
WO 8903197 Apr 1989 WO
WO 9005554 May 1990 WO
WO 9117789 Nov 1991 WO
WO 9214408 Sep 1992 WO
WO 9400178 Jan 1994 WO
WO 9400179 Jan 1994 WO
WO 9403127 Feb 1994 WO
WO 9416646 Aug 1994 WO
WO 9422379 Oct 1994 WO
WO 9427667 Dec 1994 WO
WO 9517859 Jul 1995 WO
WO 9521592 Aug 1995 WO
WO 9527448 Oct 1995 WO
WO 9529646 Nov 1995 WO
WO 9531945 Nov 1995 WO
WO 9601591 Jan 1996 WO
WO 9617645 Jun 1996 WO
WO 9619953 Jul 1996 WO
WO 9628115 Sep 1996 WO
WO 9631174 Oct 1996 WO
WO9631174 Oct 1996 WO
WO 9632078 Oct 1996 WO
WO 9633677 Oct 1996 WO
WO 9640000 Dec 1996 WO
WO 9641589 Dec 1996 WO
WO 9709932 Mar 1997 WO
WO 9716133 May 1997 WO
WO 9721401 Jun 1997 WO
WO 9721403 Jun 1997 WO
WO 9726939 Jul 1997 WO
WO 9732546 Sep 1997 WO
WO 9748343 Dec 1997 WO
WO 9811847 Mar 1998 WO
WO 9819625 May 1998 WO
WO 9819629 May 1998 WO
WO 9819630 May 1998 WO
WO 9819636 May 1998 WO
WO 9823241 Jun 1998 WO
WO 9829043 Jul 1998 WO
WO 9833453 Aug 1998 WO
WO 9833454 Aug 1998 WO
WO 9846168 Oct 1998 WO
WO 9855027 Dec 1998 WO
WO 9904728 Feb 1999 WO
WO 9932051 Jul 1999 WO
WO 9943379 Sep 1999 WO
WO 9944538 Sep 1999 WO
WO 0009059 Feb 2000 WO
WO 0012016 Mar 2000 WO
WO 0018330 Apr 2000 WO
WO 0025841 May 2000 WO
WO 0044306 Aug 2000 WO
WO 0045741 Aug 2000 WO
WO 0045742 Aug 2000 WO
WO 0045743 Aug 2000 WO
WO 0048660 Aug 2000 WO
WO 0049973 Aug 2000 WO
WO 0071059 Nov 2000 WO
WO 0172240 Oct 2001 WO
WO 02066091 Aug 2002 WO
WO 02087470 Nov 2002 WO
WO 02102279 Dec 2002 WO
WO 03003944 Jan 2003 WO
WO 03073963 Sep 2003 WO
WO 2004016201 Feb 2004 WO
WO 2004080504 Sep 2004 WO
WO 2004091441 Oct 2004 WO
WO 2005-062980 Jul 2005 WO
WO 2006088638 Aug 2006 WO
WO 2008027902 Mar 2008 WO
WO 2008051941 May 2008 WO
WO 2008063496 May 2008 WO
Non-Patent Literature Citations (24)
Entry
Murayama et al., “Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: Preliminary histopathological studies in swine rete mirabile,” Neurosurgery, 43:1164-1172, 1998.
Punekar et al., “Post-surgical recurrent varicocele: efficacy of internal spermatic venography and steel-coil embolization,” Br. J. Urol., 77:124:128, 1996.
White et al., “Pulmonary Arteriovenous Malformations: Techniques and Long-term Outcome of Embolotherapy,” Radiology, 169:663-669, 1988.
JVIR Supplement, Scientific Program, SCVIR 22nd Annual Scientific Meeting, Mar. 8-13, 1997, Sheraton Washington Hotel, 8(1) Part 2, pp. 251-252, Jan.-Feb. 1997.
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority for International Application No. PCT/US2007/082165, mailed on Apr. 22, 2009, in 25 pages.
Notification Concerning Transmittal of International Preliminary Report on Patentability, issued in International Application No. PCT/US2007/082148, mailed Apr. 30, 2009.
International Search Report and Written Opinion, issued in International Application No. PCT/US2007/082165, dated Apr. 2, 2008.
International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US07/082148, mailed on Mar. 6, 2008.
Office Action issued in German Patent Application No. 202010007592.0 on Mar. 31, 2011.
Office Action issued in Israel Patent Application No. 198303 on Feb. 23, 2011.
Notification on the Grant for Patent Right for Invention issued in Chinese Patent Application No. 200780046619.4 on Nov. 29, 2011.
Office Action issued in Mexican Patent Application No. MX/a/2009/004292 on Oct. 26, 2011.
Office Action issued in Russian Patent Application No. 2009119252 on Oct. 6, 2011.
Office Action issued in Japanese Patent Application No. 2009-534804 on May 23, 2012.
Search Report and Written Opinion mailed Dec. 19, 2011 in International application No. PCT/US2011/038456.
Decision of Rejection issued in Japanese Patent Application No. 2009-534804 on Mar. 26, 2013.
Notice of Acceptance issued in Australian Patent Application No. 2007309087 on Jun. 19, 2012.
Notice of Allowance issued in Mexican Patent Application No. MX/a/2009/004292 on Feb. 12, 2013.
Notice of Reasons of Rejection issued in Japanese Patent Application No. 2012-209331 on Aug. 9, 2013.
Office Action in European Application No. 07844525.1 dated Sep. 13, 2013 in 5 pages.
Office Action issued in Australian Patent Application No. 2012202653 on May 3, 2013.
Office Action issued in Canadian Patent Application No. 2667322 on May 27, 2013.
Office Action issued in Chinese Patent Application No. 200780046619.4 on Jun. 24, 2011.
Office Action issued in Mexican Patent Application No. MX/a/2009/004292 on Jul. 3, 2012.
Related Publications (1)
Number Date Country
20080097572 A1 Apr 2008 US
Provisional Applications (1)
Number Date Country
60862456 Oct 2006 US